Connect with us

Headlines

Essilor Buys Large Stake in 2 Chinese Companies

mm

Published

on

The company also issued new revenue predictions.

Essilor has taken a 50 percent stake in Photosynthesis Group, a Hong Kong-based company that markets sunglasses and corrective lenses under a range of banners, including MJS.

Photosynthesis Group primarily operates through a network of franchised shopping mall stores in China and has begun expanding abroad in Southeast Asia.

The partnership is expected to help to drive faster growth in the Chinese optical industry, while enabling Essilor to broaden its footprint in the sunwear segment.

Separately, the France-based Essilor has also agreed to purchase a 55 percent equity interest in Jiangsu Creasky Optical, an ophthalmic lens manufacturer and distributor based in Danyang, China.

Advertisement

Jiangsu Creasky Optical employs more than 300 people and primarily serves the domestic market. Its acquisition, which is subject to regulatory approval, is designed to expand Essilor’s offering in the Chinese mid-range segment.

According to a press release: “Together, these two partnerships attest to Essilor’s strong acquisitions dynamic in 2016, which is expected to result in a scope effect of around 4% for the year.”

Essilor now projects revenue growth to end the year at around 3.5 percent, which it says reflects the temporary slowdown in the ophthalmic optical market in the U.S. and several other leading geographies, as well as October revenue performance. the company had previously predicted 4.5 percent.

The company added: “The solid growth anticipated therefore in full-year revenue at constant exchange rates reflects the strengthening of the Company’s positions across the global marketplace.”

Contribution from operations is now expected to stand at around 18.5 percent of revenue, primarily due to the slower than expected like-for-like growth and the dilution from the sustained acquisitions dynamic.

Advertisement

SPONSORED VIDEO

Sponsored by Varilux

Introducing the VariluxⓇ Challenge

You’re faced with a variety of progressive lenses to recommend to your patients, but they are not created equal. When Eyecare Professionals insisted on Varilux lenses with every presbyopic patient for 30 days, not only did they provide sharp, seamless vision so that their patients could truly see no limits, but they also created trust, loyalty and increased profitability. See for yourself and take the Varilux Challenge today at VariluxChallenge.com.

#VariluxChallenge #InsistOnVarilux

Promoted Headlines

Advertisement

Advertisement

Subscribe


BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Advertisement

Most Popular